Literature DB >> 6270301

Electrophysiological response of cerebellar Purkinje neurons to leukotriene D4 and B4.

M R Palmer, W R Mathews, B J Hoffer, R C Murphy.   

Abstract

The biological effects of leukotrienes B4 and D4, two recently characterized products of arachidonic acid metabolism, were studied on the guinea-pig ileum in vitro and on rat cerebellar Purkinje cells in vivo. Leukotriene D4 induced contraction of the ileum and a prolonged excitation of Purkinje cells. Both of these effects were antagonized by the "slow reacting substance" end-organ antagonist, FPL 55712. Leukotriene B4 had no central electrophysiological effects at the doses used and no effects on the guinea-pig ileum at doses below 0.2 microM. Taken together with previous studies, these data suggest that leukotrienes with slow reacting substance activity may modulate the excitability of central neurons as well as peripheral smooth muscle tone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270301

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro.

Authors:  C A Jacques; B W Spur; M Johnson; T H Lee
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat.

Authors:  J Filep; E Földes-Filep; J C Frölich
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

3.  Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family.

Authors:  R J Boado; W M Pardridge; H V Vinters; K L Black
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

4.  Leukotrienes in the rat central nervous system.

Authors:  J A Lindgren; T Hökfelt; S E Dahlén; C Patrono; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Montelukast reduces seizures in pentylenetetrazol-kindled mice.

Authors:  J Fleck; F R Temp; J R Marafiga; A C Jesse; L H Milanesi; L M Rambo; C F Mello
Journal:  Braz J Med Biol Res       Date:  2016-02-23       Impact factor: 2.590

Review 6.  Montelukast: The New Therapeutic Option for the Treatment of Epilepsy.

Authors:  Bekalu Amare Tesfaye; Haftom Gebregergs Hailu; Kaleab Alemayehu Zewdie; Muluken Altaye Ayza; Derbew Fikadu Berhe
Journal:  J Exp Pharmacol       Date:  2021-01-20

7.  Oxidative degradation of leukotriene C4 by human monocytes and monocyte-derived macrophages.

Authors:  M A Neill; W R Henderson; S J Klebanoff
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

8.  Leukotriene generation by eosinophils.

Authors:  A Jörg; W R Henderson; R C Murphy; S J Klebanoff
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.